Alteogen signs deal with Novartis worth up to 4.4 tln won for subcutaneous formulations
Yonhap News Agency
·
28분 전
·
2026.09.02 15:49
·
👁 1
SEOUL, Sept. 2 (Yonhap) -- South Korean biotechnology company Alteogen Inc. said...
원문 기사 읽기
en.yna.co.kr
이 기사 공유하기
관련 기사
일반
Defense chief stresses push for AI technology application in military
일반
Finance minister outlines Seoul's readiness for post-Middle East war era at G20 meeting
일반
(LEAD) Seoul shares tumble 4 pct on renewed U.S.-Iran tensions; won strengthens
일반